[HTML][HTML] Current and future biomarkers in multiple sclerosis
J Yang, M Hamade, Q Wu, Q Wang, R Axtell… - International journal of …, 2022 - mdpi.com
Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of
effective treatment for the progressive form of MS, partly due to insensitive readout for …
effective treatment for the progressive form of MS, partly due to insensitive readout for …
Current and Future Biomarkers in Multiple Sclerosis
J Yang, M Hamade, Q Wu, Q Wang… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of
effective treatment for the progressive form of MS, partly due to insensitive readout for …
effective treatment for the progressive form of MS, partly due to insensitive readout for …
Current and Future Biomarkers in Multiple Sclerosis
J Yang, M Hamade, Q Wu, Q Wang… - International …, 2022 - search.proquest.com
Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of
effective treatment for the progressive form of MS, partly due to insensitive readout for …
effective treatment for the progressive form of MS, partly due to insensitive readout for …
Current and Future Biomarkers in Multiple Sclerosis
J Yang, M Hamade, Q Wu, Q Wang, R Axtell, S Giri… - 2022 - agris.fao.org
Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of
effective treatment for the progressive form of MS, partly due to insensitive readout for …
effective treatment for the progressive form of MS, partly due to insensitive readout for …
[HTML][HTML] Current and Future Biomarkers in Multiple Sclerosis
J Yang, M Hamade, Q Wu, Q Wang… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of
effective treatment for the progressive form of MS, partly due to insensitive readout for …
effective treatment for the progressive form of MS, partly due to insensitive readout for …
Current and Future Biomarkers in Multiple Sclerosis.
J Yang, M Hamade, Q Wu, Q Wang, R Axtell… - … Journal of Molecular …, 2022 - europepmc.org
Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of
effective treatment for the progressive form of MS, partly due to insensitive readout for …
effective treatment for the progressive form of MS, partly due to insensitive readout for …
Current and Future Biomarkers in Multiple Sclerosis.
J Yang, M Hamade, Q Wu, Q Wang… - International …, 2022 - search.ebscohost.com
Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of
effective treatment for the progressive form of MS, partly due to insensitive readout for …
effective treatment for the progressive form of MS, partly due to insensitive readout for …
Current and Future Biomarkers in Multiple Sclerosis
J Yang, M Hamade, Q Wu, Q Wang… - Int J Mol …, 2022 - scholarlycommons.henryford.com
Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of
effective treatment for the progressive form of MS, partly due to insensitive readout for …
effective treatment for the progressive form of MS, partly due to insensitive readout for …